Your institution may have access to this item. Find your institution then sign in to continue.
Title
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases.
Authors
Filleul, O; Crompot, E; Saussez, S
Abstract
Bisphosphonates (BPs) are bone-remodeling inhibitors that are used to manage bone metastases and osteoporosis. Osteonecrosis of the jaw, however, can occur during treatment. This complication is poorly understood and is called "bisphosphonate-induced osteonecrosis of the jaw" (BIOJ).
Publication
Journal of cancer research and clinical oncology, 2010, Vol 136, Issue 8, p1117